Product Categories
| Country: | China |
|---|---|
| Tel: | 021-58521787 |
| Mobile: | 17701827760 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| bis(4-fluorobenzyl)amine hydrochloride | C14H13F2N | 646051-52-7 | Details |
| AZD4205 | C25H31N9O2 | 2091134-68-6 | Details |
| Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′S)-, | C53H72N2O12+2 | 96946-43-9 | Details |
| Asundexianintermediate | C16H12ClF3N4O2 | 2376389-31-8 | Details |
| C9H17NO5 | 207305-60-0 | Details |
| (2R,3R)-2,3-Dihydroxy-4-[[[4-(2-methylpropoxy)phenyl]methyl]amino]-4-oxobutanoic acid | C15H21NO6 | 2727061-36-9 | Details |
| 3-Fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperidinyl)propoxy]-4-quinolinyl]oxy]benzenamine | C25H30FN3O3 | 1290538-61-2 | Details |
| 1-methylpiperidin-4-yl (4-isobutoxybenzyl)carbamate | Details |
| Plazomicin impurity PLZA000141 | Details |
| 1-[4-(3-Chloropropoxy)-3-methoxyphenyl]ethan-1-one | C12H15ClO3 | 58113-30-7 | Details |
| BI-6727 intermediate | C12H17ClN4O | 877676-50-1 | Details |
| N-(4-fluorobenzyl)-1-methylpiperidin-4-amine | C13H19FN2 | 359878-47-0 | Details |
| Pradofloxacin HCl | C21H22ClFN4O3 | 195532-14-0 | Details |
| RO3280 intermediate | C13H15ClF2N4O | 1062246-03-0 | Details |
| 2,2'-[hexane-1,6-diylbis[oxy(3-oxopropane-3,1-diyl)]]bis[(1R, 2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium | C54H74N2O12+2 | 1193104-84-5 | Details |
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2S)-, benzenesulfonate (1:1) | C34H45NO9S | 1075727-02-4 | Details |
| WRG-28 | C21H18N2O5S | 1913291-02-7 | Details |
| Levalbuterol hydrochloride | C13H22ClNO3 | 50293-90-8 | Details |
| PM-6 | C23H28N4O2 | 1206789-73-2 | Details |
| 4-isobutoxybenzaldehyde | C11H14O2 | 18962-07-7 | Details |
| 2,2′-(1,5-Pentanediyl) bis[(1R)-1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinepropanoate | C51H66N2O12 | 64228-84-8 | Details |
| Isoquinolinium, 2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2R)-, benzenesulfonate (1:1) | C30H37NO9S | 1075727-06-8 | Details |
| Levosimendan impurity; 4-(4-(2-(dicyanomethylene)hydrazinyl)phenyl)-3-methyl-4-oxobutanoic acid | C14H12N6O | 141505-33-1 | Details |
| 4-(TRIFLUOROMETHYL)BENZHYDRAZIDE | C8H7F3N2O | 339-59-3 | Details |
| 5-methyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one | C11H12N2O | 110766-33-1 | Details |
| Asundexian | C26H21ClF4N6O4 | 2064121-65-7 | Details |
| Salbutamol sulfate;Albuterol Sulfate | C13H23NO7S | 51022-70-9 | Details |
| (1S)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline | C20H25NO4 | 4747-98-2 | Details |
| TAK-960 | C27H34F3N7O3 | 1137868-52-0 | Details |
| 7,7-dibromobicyclo[4.1.0]heptane | C7H10Br2 | 2415-79-4 | Details |
| C21H27NO4 | 85-63-2 | Details |
| VX-150 | C21H17F4N2O7P | 1793080-72-4 | Details |
| 4-isobutoxybenzaldehyde oxime | C11H15NO2 | 882035-15-6 | Details |
| （(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline acetyl-L-leucinate） | C28H40N2O7 | 141109-12-8 | Details |
| 4-fluorobenzyl (4-isobutoxybenzyl)carbamate | Details |
| Plazomicin impurity PLZC000049944 | Details |
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-(3-methoxy-3-oxopropyl)-2-methyl-, (1R,2R)- | C25H34NO6+ | 1075726-87-2 | Details |
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2S)-, | C28H40NO6 | 1075727-01-3 | Details |
| 2-hydroxy-6-methylnicotinonitrile | C7H6N2O | 4241-27-4 | Details |
| Cisatracurium Besylate | C53H72N2O12.2C6H5O3S | 96946-42-8 | Details |
| 2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridine | C8H9ClN2 | 210539-05-2 | Details |
| Macitentan | C19H20Br2N6O4S | 441798-33-0 | Details |
| Tecovirimat | C19H15F3N2O3 | 816458-31-8 | Details |
| L-Leucine,N-acetyl-, compd. with (1S)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline (1:1) | C28H40N2O7 | 50720-57-5 | Details |
| Xanomeline tartrate | C18H29N3O7S | 152854-19-8 | Details |
| 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea | C19H23FN2O2 | 1388858-78-3 | Details |
| Mefatinib Impurity 5; | C15H10ClF3N4O | 1417695-78-3 | Details |
| 6-(4-chlorophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | C11H11ClN2O | 1630760-90-5 | Details |
| HRO761 | C31H31ClF3N9O5 | 2869954-34-5 | Details |
| ((1R,2R)-2-(3-(tert-butoxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium benzenesulfonate) | C34H45NO9S | 1075727-00-2 | Details |
| RO3280 | C27H35F2N7O3 | 1062243-51-9 | Details |
| BML-280 intermediate | C13H17N3O | 1021-25-6 | Details |
| 6-(4-hydroxyphenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | C11H12N2O2 | 103416-88-2 | Details |
| Isoquinolinium, 2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2R)-, | C24H32NO6+ | 1075727-04-6 | Details |
| AZD4604 | C28H31F2N7O4S | 2241039-81-4 | Details |
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-(3-methoxy-3-oxopropyl)-2-methyl-, iodide (1:1), (1R,2R)- | C25H34INO6 | 1075726-91-8 | Details |
| Plazomicin intermediate PLZA000004 | C46H73N7O19 | 2306236-35-9 | Details |
| (±)-Laudanosine | C21H27NO4 | 1699-51-0 | Details |
| Deuterium SPH7050 | Details |
| SPH3127 impurityH | Details |
| N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(N-methylpicolinamide) | 1116020-87-1 | Details |
| 5-(2-bromoacetyl)-2-hydroxybenzyl acetate | Details |
| 1,1,3-tris(4-isobutoxybenzyl)urea | Details |
| SPH3127 2470-C1impurity；methyl (3-(3-carbamoyl-6-methyl-1H-pyrazolo[3,4-b]pyridin-1-yl)propyl)carbamate | Details |
| 2-[(2,4-difluorophenyl)methylene]-N-[3-fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperidinyl)propoxy]-4-quinolinyl]oxy]phenyl]-, (2E)-Hydrazinecarboxamide | C33H34F3N5O4 | 1428787-71-6 | Details |
| Plazomicin impurity PLZA000005 | C51H81N7O21 | 1154758-62-9 | Details |
| 2,2'-[hexane-1,6-diylbis[oxy(3-oxopropane-3,1-diyl)]]bis[(1R, 2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium | C60H79N2O15S+ | 1193104-85-6 | Details |
| (E)-1-(4-(3-chloropropoxy)-5-methoxy-2-nitrophenyl)-3-(dimethylamino)prop-2-en-1-one | C15H19ClN2O5 | 1449763-02-3 | Details |
| SPH5030-SM3 (R,Z)-2-fluoro-3-(1-methylpyrrolidin-2-yl)acrylic acid | C8H12FNO2 | 2577289-51-9 | Details |
| 2-[[4-(2-Methylpropoxy)phenyl]methyl]-1H-isoindole-1,3(2H)-dione | C19H19NO3 | 21244-29-1 | Details |
| Plazomicin impurity PLZA000003 | C37H58N6O15 | 1154758-55-0 | Details |
| 7,7-dichlorobicyclo[4.1.0]heptane | C7H10Cl2 | 823-69-8 | Details |
| Plazomicin impurity PLZC001474 | Details |
| 4-(2-(4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenoxy)-1-hydroxyethyl)-2-(hydroxymethyl)phenol | Details |
| NLRP3-IN-25 | C17H19F3N4O5S | 2660230-90-8 | Details |
| 6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-4(1H)-Quinolinone; | C17H22N2O3 | 205448-56-2 | Details |
| 4-(trifluoromethyl)-N'-(4-(trifluoromethyl)benzoyl)benzohydrazide | C16H10F6N2O2 | 69780-61-6 | Details |
| diethyl 2-(2-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazono)malonate | C18H22N4O5 | 2445547-93-1 | Details |
| SPH5030-SM3-Z2 (S,Z)-2-fluoro-3-(1-methylpyrrolidin-2-yl)acrylic acid Hydrochloride Salt | Details |
| tert-butyl (R)-3-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propanoate oxalate | Details |
| M-7 | 2418577-74-7 | Details |
| 2,2′-(1,5-Pentanediyl) bis[(1R)-1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinepropanoate | C57H72N2O15S | 1253910-09-6 | Details |
| SPH3127 | C22H32N6O4 | 1399849-02-5 | Details |
| Plazomicin impurity PLZA000007 | C45H80N6O18 | 2306236-37-1 | Details |
| (S)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline | C21H27NO4 | 2688-77-9 | Details |
| 1,3-bis(4-isobutoxybenzyl)urea | C23H32N2O3 | 955997-87-2 | Details |
| BML-280 | C25H27N5O2 | 1158347-73-9 | Details |
| 6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-4-Quinolinol | C18H25N3O3 | 1494544-04-5 | Details |
| bis(4-isobutoxybenzyl)amine hydrochloride | C22H31NO2 | 2322278-87-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||